Trial Profile
Efficacy and toxicity of cetuximab combined with pemetrexed in patients with fluorouracil-based pre-treated metastatic esophageal squamous cell carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Pemetrexed (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Feb 2016 New trial record